Clearmind Medicine Inc.
CMND· Nasdaq
CMNDClearmind Medicine Inc.
Source filing unavailable
| Metric | Q3 2025 | Q3 2024 |
|---|---|---|
| Net Income | -$1.31M | -$2.09M |
| EPS Diluted | -$0.25 | -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Clearmind Medicine Inc. · CIK 1892500 · Engraved from SEC EDGAR
